Last10K.com

Aemetis, Inc (AMTX) SEC Filing 10-K Annual report for the fiscal year ending Thursday, December 31, 2015

Aemetis, Inc

CIK: 738214 Ticker: AMTX
Exhibit 99.1
 

 
 
Investor Relations/Company/Media Contact:
Satya Chillara
(408) 213-0939
schillara@aemetis.com

Aemetis Reports Fourth Quarter and Year-End 2015 Results

CUPERTINO, Calif. – March 24, 2016 -
Aemetis, Inc. (NASDAQ: AMTX), an advanced renewable fuels and biochemicals company, today announced its financial results for the fourth quarter and twelve months ended December 31, 2015.

Financial Highlights for 2015

●  
Revenues of $147 million in 2015, down from $208 million in 2014
●  
Adjusted EBITDA of $(3) million in 2015, down from $30 million in 2014
●  
$22 million of EB-5 funding released to the company from escrow during 2015
 
“In 2015, our financial and operational performance was affected by excess supply in ethanol markets,” said Eric McAfee, Chairman and Chief Executive Officer of Aemetis.  “During this past year, Aemetis significantly increased production at our biodiesel and glycerin biorefinery in India, to take advantage of deregulation and the removal of subsidies in the diesel market.  The biodiesel domestic market in India continues to grow, with our expanding sales of B100 as a transportation fuel to replace diesel.  In 2016, we plan to increase the profitability of our ethanol business by the adoption of patented technologies for the production of cellulosic ethanol and related products at the Keyes plant,” added McAfee.
 
Today, Aemetis will host an earnings review call at 10:00 am Pacific (PT). For details on the call, visit: http://www.aemetis.com/investors/conference-call/
 
 
 

The following information was filed by Aemetis, Inc (AMTX) on Thursday, March 24, 2016 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Aemetis, Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aemetis, Inc.

Continue

Assess how Aemetis, Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aemetis, Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2016 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations And Comprehensive Income (loss)
Consolidated Statements Of Stockholders Equity
1. Nature Of Activities And Summary Of Significant Accounting Policies
1. Nature Of Activities And Summary Of Significant Accounting Policies (details 1)
1. Nature Of Activities And Summary Of Significant Accounting Policies (details Narrative)
1. Nature Of Activities And Summary Of Significant Accounting Policies (details)
1. Nature Of Activities And Summary Of Significant Accounting Policies (policies)
1. Nature Of Activities And Summary Of Significant Accounting Policies (tables)
10. Fair Value Measurements
10. Fair Value Measurements (details 1)
10. Fair Value Measurements (details)
10. Fair Value Measurements (tables)
11. Stock-based Compensation
11. Stock-based Compensation (details 1)
11. Stock-based Compensation (details 2)
11. Stock-based Compensation (details)
11. Stock-based Compensation (tables)
12. Agreements
12. Agreements (details)
12. Agreements (tables)
13. Segment Information
13. Segment Information (details 1)
13. Segment Information (details)
13. Segment Information (tables)
14. Quarterly Financial Data (details) (usd $)
14. Quarterly Financial Data (tables)
14. Quarterly Financial Data (unaudited)
15. Related Party Transactions
15. Related Party Transactions (details Narrative)
16. Income Tax
16. Income Tax (details 1)
16. Income Tax (details 2)
16. Income Tax (details 3)
16. Income Tax (details Narrative)
16. Income Tax (tables)
17. Parent Company Financial Statements (details 1)
17. Parent Company Financial Statements (details 2)
17. Parent Company Financial Statements (tables)
17. Parent Company Financial Statements (unaudited)
17. Parent Company Financial Statements (unaudited) (details)
18. Subsequent Events
19. Management's Plan
2. Inventory
2. Inventory (details)
2. Inventory (tables)
3. Property, Plant And Equipment
3. Property, Plant And Equipment (details 1)
3. Property, Plant And Equipment (details Narrative)
3. Property, Plant And Equipment (details)
3. Property, Plant And Equipment (tables)
4. Intangible Assets And Goodwill
4. Intangible Assets And Goodwill (details 1)
4. Intangible Assets And Goodwill (details Narrative)
4. Intangible Assets And Goodwill (details)
4. Intangible Assets And Goodwill (tables)
5. Notes Payable
5. Notes Payable (details 1)
5. Notes Payable (details Narrative)
5. Notes Payable (details)
5. Notes Payable (tables)
6. Commitments And Contingencies
6. Commitments And Contingencies (details Narrative)
6. Commitments And Contingencies (details)
6. Commitments And Contingencies (tables)
7. Stockholders Equity' (details)
7. Stockholders' Equity
7. Stockholders' Equity (tables)
8. Outstanding Warrants
8. Outstanding Warrants (detail 1)
8. Outstanding Warrants (details)
8. Outstanding Warrants (tables)
9. Fair Value Of Warrants
9. Fair Value Of Warrants (details)
9. Fair Value Of Warrants (tables)
Ticker: AMTX
CIK: 738214
Form Type: 10-K Annual Report
Accession Number: 0001354488-16-006728
Submitted to the SEC: Mon Mar 28 2016 5:43:18 PM EST
Accepted by the SEC: Tue Mar 29 2016
Period: Thursday, December 31, 2015
Industry: Industrial Organic Chemicals

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/amtx/0001354488-16-006728.htm